View Author
cancer study migrant population breast country tumor patient mortality factor incidence breast cancer women birth stomach group health disease survival tamoxifen cohort level death adam -9 netherland registry difference therapy number treatment dutch result immigrant cancer incidence -11 england adam -11 tamoxifen therapy european ethnicity screening status cancer risk liver stage origin wales response signi ficantly stomach cancer cancer mortality mortality data database sweden fication month germany risk factors progression-free survival census change disease control study cohort effect infection pattern nuclei swedish table comparison identi residence france migration diagnosis information protein dutch natives non-western countries analysis
3 Most Recent Publications
|
Breast and stomach cancer incidence and survival in migrants in the Netherlands, 1996-2006
(Article)
Arnold, M. Aarts, M.J. Siesling, S. Aa, M.A.E.M. van der Visser, O. Coebergh, J.W.W. |
2011-05-01
|
|
Cancer risk diversity in non-western migrants to Europe: An overview of the literature
(Article)
Arnold, M. Razum, O. Coebergh, J.W.W. |
2010-09-01
|
|
How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
(Article)
Sieuwerts, A.M. Meijer van Gelder, M.E. Timmermans, M.A. Trapman, A.M. Garcia, R.R. Arnold, M. Goedheer, A.J. Portengen, H. Klijn, J.G.M. Foekens, J.A. |
2005-10-15
|
